Tag: Bharat Biotech

The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.

New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed as required, is well-tolerated and immunogenic in the paediatric population ...

Hyderabad: The World Health Organization (WHO) is a step closer to granting an emergency use listing (EUL) to Covaxin after Bharat Biotech provided additional data on the vaccine sought by ...

Bhubaneswar: Odisha on Tuesday received 1,11,100 doses of state-procured Covaxin vaccine. The consignment reached Bhubaneswar in a special flight. The vaccine manufactured by Bharat Biotech is administered to eligible beneficiaries ...

New Delhi: The supply price of COVID-19 vaccine Covaxin to the Central government at Rs 150 per dose is not sustainable in the long run, Bharat Biotech said on Tuesday. ...

Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences (AIIMS) Patna. The Drugs Controller General of India last month ...

New Delhi: The Delhi High Court on Wednesday heard a PIL, to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech for conducting the ...

New Delhi: COVID-19 vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) will get Rs 1,500 crore and Rs 3,000 crore each as supply credit from the Finance Ministry. ...

Bhubaneswar: All frontline workers will be vaccinated at their respective workplace, said Director, Health and Family Welfare Bijay Panigrahi here on Wednesday. The vaccination of frontline workers will begin from ...

New Delhi: Bharat Biotech's Covaxin is effective against the UK variant of the virus.  Taking to Twitter, Bharat Biotech said "Covaxin effectively neutralises UK variants of SARS-CoV-2 reducing the possibility ...